Course Learning Objectives
Upon the conclusion of this program, participants should be able to:

• Describe bleeding risk with “triple therapy” post PCI;
• Review  current data regarding dual therapy combinations;
• Review the use of OCT and IVUS in assisting with PCI and plaque assessment;
• Describe coronary physiology;
• Review the principles of CFR, FFR, and iFR;
• Determine reperfusion strategy for STEMI patients who present to facilities without PCI capability;
• Review current evidence for the invasive management of Non-STE- ACS patients;
• Identify the selection criteria and outcome data for Mitral Clip;
• Distinguish the indications, complications, and long-term outcomes of TAVR.

Target Audience
This enduring program is designed for, but not limited to, cardiologists and cardiovascular fellows preparing for the ABIM Interventional Cardiology certification/recertification exam. However, this course also provides a focused state-of-the-art review of interventional cardiology topics for all cardiovascular practitioners and trainees.

Content of this course  MP4+PDFs+Slides

Friday – THE BASICS
Drugs You Need to Know I
Radiation Physics, Imaging, Risks, and Safety
Drugs You Need to Know II
Panel Questions | Drs. Yang and Fetterly

Friday – ANTITHROMBOTIC THERAPY
Antiplatelet Therapy: Clinical Application in PCI
Anticoagulation and Triple Therapy
Bleeding Risks and Management
Moderated Panel Discussion | Drs. Casanegra, Eleid, and Singh

Friday – PATHOPHYSIOLOGY AND ASSESSMENT OF ATHEROSCLEROSIS
Coronary Anomalies, Tips and Tricks
Pathophysiology of Stable and Unstable Coronary Syndromes
Intracoronary Imaging: Plaque Characterization, OCT, IVUS
Intracoronary Physiology: FFR, iFR, and CFR
Moderated Panel Discussion| Drs. Best, Prasad, Sandoval

Friday – PERIPHERAL ARTERIAL DISEASE AND INTERVENTIONS
Diagnosis and Management of Peripheral Arterial Disease (PAD)
Carotid Artery Disease and Interventions
Panel Questions| Drs. Shuja, Exaire, Gulati

Saturday – PCI: RISK ASSESSMENT AND REDUCTION
Reperfusion Therapies in STEMI
Invasive Strategies in Non STE-ACS
Quality, Appropriateness, and Performance Metrics
Panel Questions | Drs. Yang and Barsness
Management of Cardiogenic Shock
Transradial PCI
Device Selection
Moderated Panel Discussion | Drs. Yang, Barsness, Gulati and Sandhu

Saturday – CASE-BASED MANAGEMENT OF SELECT PATIENT AND LESION SUBSETS
Athero-Ablative Techniques
Left Main and Bifurcation Disease
Chronic Total Occlusions
Saphenous Vein Grafts
Restenosis and Stent Thrombosis: Key Points for the Boards
Management PCI Complications
Panel Questions | Drs. Yang, Gharacholou, Prasad, Barsness, and Gulati

Sunday – STRUCTURAL HEART DISEASE
Percutaneous Management of Atrial Septic Defect, Patent Foramen Ovale, and Ventricular Septal Defect
Percutaneous Management of Tricuspid Valve, Pulmonic Valve, and Coarctation of the Aorta
Transcatheter Aortic Valve Replacement
Septal Ablation for Hypertrophic Cardiomyopathy
Mitral Valve Interventions
Left Atrial Appendage Closure
Management of Structural Complications
Panel Questions | Drs. Reeder, Anderson, Pollak, Eleid, Guerrero, Alkhouli, Pollak, and Gulati

SUPPLEMENTAL MATERIAL
Medical Statistics: Pearls for the Boards
Acute Stroke Intervention
Clinical Application of the Universal Definition of MI: Cardiac Troponin for Myocardial Injury and Infarction
Clinical Application of the Universal Definition of MI: Non-Atherothrombotic Supply-Demand Type 2 MI
Myocardial Infarction Associated with PCI
Diagnosis and Management of PAD
Out of Hospital Cardiac Arrest Management

Date of Original Release: October 8, 2021